NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding NextCure, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 92 | 78 | −14 |
| Shares | 18.0M | 15.5M | −2.50M (−13.9%) |
| Value | $179.8M | $124.2M | −$55.6M (−30.9%) |
New holders (14)
Institutions that held NextCure, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Federated Hermes, Inc. | 510,283 | $4.10M | 0.01% |
| Tang Capital Management LLC | 300,000 | $2.41M | 0.48% |
| Silverarc Capital Management, LLC | 285,498 | $2.29M | 1.21% |
| Highland Capital Management Fund Advisors, L.P. | 234,708 | $1.89M | 0.41% |
| Renaissance Technologies LLC | 200,300 | $1.61M | 0.00% |
| Bridgeway Capital Management, LLC | 110,000 | $883.0K | 0.02% |
| Ergoteles LLC | 75,100 | $603.0K | 0.01% |
| Tibra Equities Europe Ltd | 41,100 | $330.0K | 0.10% |
| Veritable, L.P. | 36,807 | $296.0K | 0.00% |
| Trexquant Investment LP | 17,202 | $138.0K | 0.01% |
| Jump Financial, LLC | 16,769 | $135.0K | 0.01% |
| Jane Street Group, LLC | 15,124 | $121.0K | 0.00% |
| Assenagon Asset Management S.A. | 13,551 | $109.0K | 0.00% |
| Point72 Hong Kong Ltd | 11 | $0 | 0.00% |
Sold out (28)
Institutions that held NextCure, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.